Conciseness

The body is command-first and lean, but the Overview defines what de novo design is ('the computational generation of novel molecular structures with desired properties, without starting from known active compounds') — a concept Claude already knows — and a couple of Tips run slightly long. Minor over-explanation, matching anchor 4 rather than 5.

Actionability

Every workflow provides copy-paste-ready CLI invocations with realistic flags and values (e.g. '--smiles "c1ccc(NC(=O)c2ccccc2)cc1" ... --strategy all', '--filters lipinski,veber,qed,pains,brenk,leadlike,fragmentlike,bro5'), documents output CSV columns ('id, smiles, mw, logp, qed, tanimoto_to_parent, strategy'), and gives concrete thresholds — covering the common cases fully.

Workflow Clarity

A scenario-to-script selection table plus sequenced workflows and an explicit pipeline order ('Start broad, then narrow') make the sequence clear, and checkpoints appear via 'Deduplicate early', SA-threshold guidance, and property-distribution checks. However, the batch-generation workflows lack an explicit validate-on-failure/retry loop, so it does not reach anchor 5.

Progressive Disclosure

Sections are well organized, and every referenced script (generate_analogs.py, generate_fragments.py, generate_sbdd.py, optimize.py, filter.py) exists in the bundle as a one-level-deep reference. Minor gap: bulk reference material such as the full filter-threshold list and bioisostere dictionaries is inlined in SKILL.md rather than split into reference files.

Specificity

The description lists five concrete, distinct capabilities ('Scaffold-based analog enumeration, fragment growing/linking, structure-based design, multi-objective optimization, and drug-likeness filtering'), fully covering the skill's actual functionality with no minor gaps that would drop it to 4.

Completeness

The 'what' is clearly and comprehensively answered, but there is no 'Use when...' clause or equivalent explicit trigger guidance, which per the rubric caps completeness at 3.

Trigger Term Quality

Natural medicinal-chemistry phrases are present ('de novo', 'drug discovery', 'scaffold', 'fragment', 'drug-likeness'), but common variations users might say are missing, such as 'lead optimization', 'generate molecules', 'analog library', or named filters like Lipinski/PAINS.

Distinctiveness Conflict Risk

It occupies a clear niche (de novo molecule generation for drug discovery) with vocabulary distinct from adjacent skills (e.g., general cheminformatics or docking skills), so wrong-skill triggering risk is minimal.